Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine
 Disease Category: Breast Cancer
Location: United States, CA

Trial Information

A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer

You have been asked to participate in this research study because you have Invasive Ductal Breast Cancer (IDBC). Invasive Ductal Carcinoma (IDC) is a very common type of breast cancer. It starts developing in the milk ducts of your breast, but breaks out of the duct tubes, and invades, or infiltrates, surrounding tissues. Invasive ductal carcinoma accounts for about 8 out of 10 of all invasive breast cancers. The purpose of this research study is to evaluate the changes in biomarkers (protein(s)) before and after a single dose of Zoledronic acid the study medication. Your time on this study is expected to last approximately 6 weeks.

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.